Modern eye surgery has become one of the safest medical procedures available today.
Millions of people undergo cataract surgery and other eye operations every year and recover successfully with improved vision.
Advances in surgical techniques, sterile equipment, medications, and training have dramatically reduced the risk of complications. For most patients, eye surgery is routine and highly effective.
Even so, doctors remain alert for a rare but potentially devastating complication known as endophthalmitis. Although uncommon, this serious bacterial infection can develop inside the eye after surgery and may threaten a person’s vision within a very short period of time.
If the infection is not treated quickly, permanent vision loss can occur. Because endophthalmitis is relatively rare, many people have never heard of it. The condition develops when bacteria enter the eye and begin multiplying inside delicate tissues that are essential for vision.
The infection triggers severe inflammation and can rapidly damage structures that allow people to see clearly. Symptoms often include eye pain, redness, worsening vision, sensitivity to light, and swelling. Doctors have traditionally focused on how well a patient can see at the time the infection is diagnosed.
Visual acuity has long been one of the main factors guiding treatment decisions. However, new research suggests that another factor may be equally important: identifying exactly which bacteria are causing the infection.
Researchers at the University of Utah’s John A. Moran Eye Center have now provided important evidence that not all cases of endophthalmitis behave the same way. Their findings suggest that some bacteria are far more dangerous than others and may require faster or more aggressive treatment.
The study was led by eye disease specialists Christopher Conrady, Akbar Shakoor, and Albert T. Vitale. The team examined more than 240 cases of endophthalmitis treated between 2012 and 2022 across four academic medical centers.
By studying a large number of patients over a ten-year period, the researchers were able to identify patterns that may help improve future care. Their analysis showed that the type of bacteria responsible for the infection strongly influenced patient outcomes.
Some bacteria caused infections that responded relatively well to treatment and allowed many patients to recover useful vision. Other bacteria caused much more aggressive disease that led to severe complications and permanent visual damage. The researchers found that certain species of Streptococcus and Enterococcus were particularly dangerous.
Patients infected with these bacteria were significantly more likely to suffer severe vision loss compared with patients infected by more common bacteria normally found on the surface of the eye or skin.
This discovery is important because it suggests that doctors should not view all cases of endophthalmitis as equal. Two patients may arrive with similar symptoms, yet their chances of recovery may be very different depending on the bacteria causing the infection.
The findings may also influence how doctors decide between different treatment options. Endophthalmitis is commonly treated with antibiotics injected directly into the eye. In more severe cases, surgeons may perform a procedure called vitrectomy, which removes infected fluid from inside the eye.
If doctors can quickly identify highly aggressive bacteria, they may be able to intervene earlier and improve the chances of preserving vision. One challenge is that identifying the specific bacteria responsible for an infection can take time.
Laboratory testing often requires samples to be collected and cultured before results become available. During this waiting period, the infection may continue to damage the eye. The researchers believe that faster diagnostic tools could play a major role in improving patient outcomes.
New technologies that rapidly identify bacteria may allow doctors to make more personalized treatment decisions and begin appropriate therapies sooner. The study also highlights how much of today’s endophthalmitis treatment is still influenced by a landmark study published in 1996.
While that research provided valuable guidance, medical science has advanced significantly since then. The new findings suggest that modern approaches may need to consider additional factors beyond visual acuity alone.
In a related editorial published in Ophthalmology, Christopher Conrady emphasized the need for more research and better diagnostic methods. The research was published in the American Journal of Ophthalmology. The study’s strengths include its large sample size and multi-center design.
However, it was observational, meaning it cannot prove cause and effect. More studies are needed to determine exactly how treatment should change based on bacterial type. Overall, the findings suggest that identifying dangerous bacteria earlier may help doctors protect patients’ vision more effectively.
If you care about eye health, please read studies about how vitamin B may help fight vision loss, and MIND diet may reduce risk of vision loss disease.
For more information about eye disease, please see recent studies about how to protect your eyes from glaucoma, and results showing this eye surgery may reduce dementia risk.
Source: University of Utah.
